1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Comparison of patients according to FVH scorea
FVH ScoreP Value
0–1 (n = 19)2–3 (n = 63)4–5 (n = 113)6–7 (n = 49)
Age (yr)73 (60–80)70 (57–79)71 (56–80)67 (62–77).339
Male (No.) (%)12 (63)31 (49)68 (60)27 (55).500
Hypertension (No.) (%)b12 (63)38 (60)58 (51)26 (53).537
Diabetes mellitus (No.) (%)b4 (21)9 (14)13 (12)6 (12).708
Hyperlipidemia (No.) (%)b9 (47)18 (29)43 (38)18 (37).477
Current smoking (No.) (%)c3 (16)12 (19)23 (20)10 (20).954
Systolic BP (mm Hg)148 (140–172)159 (142–173)151 (139–167)148 (134–160).071
Diastolic BP (mm Hg)87 (76–93)84 (69–95)80 (70–89)80 (72–90).334
Serum glucose (mmol/L)d6.6 (5.5–8.1)6.7 (5.4–7.3)6.4 (5.5–7.6)6.0 (5.3–7.0).189
Baseline NIHSS scoreb13 (8–20)13 (7–18)15 (8–20)15 (11–21).321
Onset-to-MRI time (min)142 (84–196)115 (89–176)115 (91–151)97 (83–130).007
Proximal occlusion (No.) (%)6 (31)31 (49)81 (72)43 (88)<.001
DWI1 volume (mL)24 (12–102)19 (5–67)18 (7–49)12 (6–34).077
Tmax >10-sec volume (mL)26 (5–76)17 (4–43)24 (11–53)30 (11–64).200
Tmax >6-sec volume (mL)65 (19–133)47 (19–102)78 (40–123)96 (66–134).002
HIR ≤ 0.35 (No.) (%)6 (32)30 (48)54 (47)32 (65).057
HIR0.44 (0.30–0.54)0.39 (0.19–0.48)0.33 (0.19–0.47)0.32 (0.14–0.44).049
PWI-DWI mismatch (No.) (%)6 (32)32 (51)71 (63)35 (51).011
DWI2 volume (mL)73 (14–150)43 (13–147)37 (13–104)29 (12–52).075
24-hr infarct growth (mL)27 (2–87)19 (4–57)14 (1–45)13 (4–28).125
Complete recanalization (No.) (%)7 (37)19 (30)38 (34)21 (43).551
ENI (No.) (%)e7 (37)12 (20)30 (27)29 (53)<.001
3-mo mRS ≤ 1 (No.) (%)f3 (17)14 (24)35 (34)22 (45).039
3-mo mRS ≤ 2 (No.) (%)f9 (47)26 (41)47 (42)32 (65).057
  • Note:—ENI indicates early neurologic improvement; BP, blood pressure.
  • ↵a Unless specified, numbers are median (interquartile range).
  • ↵b Missing data for 4 patients.
  • ↵c Missing data for 9 patients.
  • ↵d Missing data for 13 patients.
  • ↵e Missing data for 5 patients.
  • ↵f Missing data for 18 patients.